Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure
Explore the source record for details and available documents.
SEARCH · Engineering Papers
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Schistosomiasis is a major human parasitic disease afflicting more than 250 million people, historically treated with chemotherapies praziquantel or oxamniquine. Since oxamniquine is species-specific, killing Schistosoma mansoni but not other schistosome species ( S. haematobium or S. japonicum ) and evidence for drug resistant strains is growing, research efforts have focused on identifying novel approaches. Guided by data from X-ray crystallographic studies and Schistosoma worm killing assays on oxamniquine, our structure-based drug design approach produced a robust structure–activity relationship (SAR) program that identified several new lead compounds with effective worm killing. We report these studies culminated in the discovery of compound 12a , which demonstrated broad-species activity in killing S. mansoni (75%), S. haematobium (40%), and S. japonicum (83%).
Abstract not provided
Abstract not provided
Abstract not provided
Not Available
Not Available
Baeyer–Villiger monooxygenases (BVMOs) have been shown to play key roles for the biosynthesis of important natural products. MtmOIV, a homodimeric FAD- and NADPH-dependent BVMO, catalyzes the key frame-modifying steps of the mithramycin biosynthetic pathway, including an oxidative C–C bond cleavage, by converting its natural substrate premithramycin B into mithramycin DK, the immediate precursor of mithramycin. The drastically improved protein structure of MtmOIV along with the high-resolution structure of MtmOIV in complex with its natural substrate premithramycin B are reported here, revealing previously undetected key residues that are important for substrate recognition and catalysis. Kinetic analyses of selected mutants allowed us to probe the substrate binding pocket of MtmOIV and also to discover the putative NADPH binding site. This is the first substrate-bound structure of MtmOIV providing new insights into substrate recognition and catalysis, which paves the way for the future design of a tailored enzyme for the chemo-enzymatic preparation of novel mithramycin analogues.
The fundamental role of halide anions in the seed-mediated synthesis of anisotropic noble metal nanostructures has been a subject of debate within the nanomaterials community. Herein, we systematically investigate the roles of chloride, bromide and iodide anions in mediating the growth of anisotropic Au nanostructures. A high-purity surfactant solution of hexadecyltrimethylammonium bromide (CTABr) is used to reliably probe the role of each halide anion without interference from impurities. Our investigation reveals that bromide anions are required for the formation of Au nanorods, while the controlled combination of both bromide and iodide anions are necessary for the production of high-quality Au nanoprisms. Chloride anions, however, are ineffective at promoting anisotropic architectures and are detrimental to nanorod and/or nanoprism growth at high concentrations. We examine the seed structure and propose a growth model based on facet-selective adsorption on low-index Au facets to rationalize the nanostructures obtained by these methods. Our approach provides a facile synthesis of anisotropic Au nanostructures by way of a single growth solution and yields the desired morphologies with high purity. These results demonstrate that appropriate combinations of halide anions provide a versatile paradigm for manipulating the morphological distribution of Au nanostructures.
Not Available
Explore the source record for details and available documents.